High Court Won't Weigh Suit Over Generic Reglan Labeling
The U.S. Supreme Court on Monday declined to hear an appeal of a Sixth Circuit ruling dismissing three failure-to-warn suits targeting Barr Pharmaceuticals and other drugmakers over generic versions of heartburn...To view the full article, register now.
Already a subscriber? Click here to view full article